First-Line Treatment of Oligoarticular Juvenile Idiopathic Arthritis Targeting Inactive Disease
Clinical Scenario
Oligoarticular juvenile idiopathic arthritis (oligoarticular JIA) is a chronic inflammatory joint condition in children characterized by involvement of four or fewer joints. Prompt first-line intervention aims to control active arthritis and achieve the primary clinical goal of inactive disease.
Initial Therapy — Partial Overview
Initial management includes a structured approach combining scheduled anti-inflammatory therapy with a targeted local joint intervention when appropriate — with agent selection and clinical sequencing guided by evidence-based recommendations.
Clinical goal: Inactive disease
References
DOI: 10.1002/art.42037
- A trial of scheduled NSAIDs is conditionally recommended as part of initial therapy for active oligoarthritis.
- Intraarticular glucocorticoids (IAGCs) are strongly recommended as part of initial therapy for active oligoarthritis.
- Triamcinolone hexacetonide is strongly recommended as the preferred agent.
- However, the initial NSAID trial should be brief due to potential adverse effects (e.g., gastritis, bruising) and limited efficacy (unless inactive disease is achieved).
View source ↗